Eli Lilly’s CEO said supply of Zepbound, the drugmaker’s new weight loss drug, might not meet 2024 demand.
Read the full post on Becker's Hospital Review - Healthcare News
Eli Lilly’s CEO said supply of Zepbound, the drugmaker’s new weight loss drug, might not meet 2024 demand.
Read the full post on Becker's Hospital Review - Healthcare News